Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD-Reference-Cited by-同舟云学术

Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD

Published:2015-01-15 Issue:3 Volume:125 Page:570-580
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Hechinger Anne-Kathrin¹,Smith Benjamin A. H.¹,Flynn Ryan²,Hanke Kathrin¹,McDonald-Hyman Cameron²,Taylor Patricia A.²,Pfeifer Dietmar¹,Hackanson Björn¹,Leonhardt Franziska¹³,Prinz Gabriele¹,Dierbach Heide¹,Schmitt-Graeff Annette⁴,Kovarik Jiri⁵,Blazar Bruce R.²,Zeiser Robert¹

Affiliation:

1. Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany;

2. Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN;

3. Genetics Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany;

4. Department of Pathology, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany; and

5. Novartis Institutes for Biomedical Research, Basel, Switzerland

Abstract

Key Points Monoclonal antibody blockade of the common γ chain attenuates acute and chronic GVHD. Common γ-chain cytokines increase granzyme B levels in CD8 T cells, which are reduced upon CD132 blockade in vivo.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/125/3/570/1345018/570.pdf

Reference49 articles.

1. Pasquini MC Wang Z Current use and outcome of hematopoietic stem cell transplantation. CIBMTR summary slides. Available at: http://www.cibmtr.org/referencecenter/slidesreports/summaryslides/pages/index.aspx. Accessed November 5, 2014

2. Risk factors for acute GVHD and survival after hematopoietic cell transplantation.;Jagasia;Blood,2012

3. Graft-versus-host disease.;Ferrara;Lancet,2009

4. Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance GvHD via tissue damage.;Schwab;Nat Med,2014

5. MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD.;Stickel;Blood,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When is the best time and grade to start ruxolitinib in corticosteroid‐refractory acute graft‐versus‐host‐disease: A multi‐center research;Clinical Transplantation;2023-11-21

2. A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure;Transplantation and Cellular Therapy;2023-02

3. Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation;Transplantation and Cellular Therapy;2023-02

4. Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models;Science Translational Medicine;2023-01-11

5. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis;Frontiers in Surgery;2023-01-06